Insulin derivatives, processes for their preparation and their use, and pharmaceutical agents for the treatment of diabetes mellitus
US4701440A · kind A · utility
38Cited by
0References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 6, 1986 |
| Grant date | Oct 20, 1987 |
| Priority date | — |
| Expiry date | Jun 6, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to insulin derivatives of the formula I ##STR1## in which R.sup.1 denotes H or H--Phe, R.sup.30 represents the radical of a neutral L-aminoacid and R.sup.31 represents a physiologically acceptable organic group of basic character with up to 50 carbon atoms, these derivatives having an isoelectric point between 5.8 and 8.5, processes for their preparation and their use, and agents containing these derivatives for the treatment of diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.